Discover
NAGE
Niagen Bioscience, Inc.
3.33
2 x 2.39
2 x 4.16
bid
ask
+
0.14
4.39%
2 @ 07:19 AM
3.30 -0.03 (0.90%)
| Ytd | -47.64% | |
| 1y | -73.53% |
3.23
day range
3.35
3.18
52 week range
13.09
| Open | 3.24 | Prev Close | 3.19 | Low | 3.23 | High | 3.35 | Mkt Cap | 265.22M |
| Vol | 546.89K | Avg Vol | 833.31K | EPS | 0.21 | P/E | 15.86 | Forward P/E | N/A |
| Beta | 2.08 | Short Ratio | 3.35 | Inst. Own | 33.09% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-05 | 50-d Avg | 3.90 | 200-d Avg | 5.73 | 1yr Est | 14.90 |
| Income Statement | |||
| Total Revenue | 31.47M | ||
| Revenues (USD) | 31.47M | ||
| Cost of Revenue | 11.50M | ||
| Gross Profit | 19.98M | ||
| Operating Expenses | 18.40M | ||
| Research and Development Expense | 1.48M | ||
| Selling, General and Administrative Expense | 16.92M | ||
| Operating Income | 1.58M | ||
| Income Tax Expense | 417.00K | ||
| Net Income | 6.32M | ||
| Net Income Common Stock | 6.32M | ||
| Net Income Common Stock (USD) | 6.32M | ||
| Consolidated Income | 6.32M | ||
| Earnings per Basic Share | 0.08 | ||
| Earnings per Basic Share (USD) | 0.08 | ||
| Earnings per Diluted Share | 0.07 | ||
| Earning Before Interest & Taxes (EBIT) | 6.74M | ||
| Earning Before Interest & Taxes (USD) | 6.74M | ||
| Weighted Average Shares | 79.92M | ||
| Weighted Average Shares Diluted | 84.57M | ||
| Balance Sheet | |||
| Cash and Equivalents | 66.55M | ||
| Cash and Equivalents (USD) | 66.55M | ||
| Trade and Non-Trade Receivables | 13.07M | ||
| Current Assets | 105.12M | ||
| Property, Plant & Equipment Net | 3.32M | ||
| Total Assets | 114.33M | ||
| Debt Current | 1.03M | ||
| Total Debt | 2.58M | ||
| Current Liabilities | 22.82M | ||
| Debt Non-Current | 1.54M | ||
| Total Liabilities | 32.00M | ||
| Accumulated Retained Earnings (Deficit) | -158.21M | ||
| Accumulated Other Comprehensive Income | -3.00K | ||
| Shareholders Equity | 82.33M | ||
| Shareholders Equity (USD) | 82.33M | ||
| Assets Non-Current | 9.21M | ||
| Total Debt (USD) | 2.58M | ||
| Deferred Revenue | 2.57M | ||
| Deposit Liabilities | 380.00K | ||
| Goodwill and Intangible Assets | 5.49M | ||
| Inventory | 24.02M | ||
| Liabilities Non-Current | 9.18M | ||
| Trade and Non-Trade Payables | 13.28M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 464.00K | ||
| Net Cash Flow from Financing | -2.29M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 1.76M | ||
| Capital Expenditure | -61.00K | ||
| Net Cash Flow - Business Acquisitions and Disposals | 5.31M | ||
| Issuance (Purchase) of Equity Shares | -2.24M | ||
| Net Cash Flow from Investing | 5.25M | ||
| Net Cash Flow from Operations | -1.19M | ||
| Share Based Compensation | 1.72M | ||